The table below shows Dipak Kanayalal Shah’s Portfolio based on the Highest Market Capitalization.
| Name | Market Cap (Cr) | Close Price (rs) |
| Borosil Ltd | 4185.68 | 365.3 |
| Gujarat Themis Biosyn Ltd | 2935.16 | 404.05 |
| Amrutanjan Health Care Ltd | 2152.23 | 744.95 |
| Arrow Greentech Ltd | 784.8 | 520.15 |
| Sunshield Chemicals Ltd | 642.55 | 873.85 |
| Indo Borax and Chemicals Ltd | 567.51 | 176.85 |
| Kilitch Drugs (India) Ltd | 548.89 | 341.3 |
| Majestic Auto Ltd | 341.19 | 328.15 |
Content:
- Who is Dipak Kanayalal Shah?
- Top Stocks Held By Dipak Kanayalal Shah
- Best Stocks Held By Dipak Kanayalal Shah
- Dipak Kanayalal Shah Net Worth
- Performance Metrics Of Dipak Kanayalal Shah’s Portfolio
- How do you invest in Dipak Kanayalal Shah’s portfolio stocks?
- Benefits of Investing in Dipak Kanayalal Shah Stock Portfolio
- Challenges Of Investing in Dipak Kanayalal Shah’s Portfolio
- Introduction to Dipak Kanayalal Shah’s Portfolio
- Dipak Kanayalal Shah Portfolio – FAQs
Who is Dipak Kanayalal Shah?
Dipak Kanayalal Shah is a notable Indian investor with a publicly disclosed net worth exceeding ₹177.9 crore, holding 39 stocks according to the latest corporate shareholdings filings. His strategic investment approach and diversified portfolio reflect his expertise in identifying high-potential opportunities across various sectors.
Shah’s investment strategy focuses on stocks with strong fundamentals and significant growth prospects. His diversified portfolio spans multiple industries, showcasing his ability to mitigate risks while maximizing returns. This approach highlights his adeptness in navigating market fluctuations and achieving consistent growth.
Beyond his investment activities, Shah’s keen market insight and thorough research contribute to his substantial net worth. His success serves as an inspiration to aspiring investors, emphasizing the importance of strategic planning and diversification in building a resilient and profitable portfolio.
Top Stocks Held By Dipak Kanayalal Shah
The table below shows the Top Stocks Held By Dipak Kanayalal Shah based on 1 Year Return.
| Name | Close Price (rs) | 1Y Return (%) |
| Gujarat Themis Biosyn Ltd | 404.05 | 150.99 |
| Majestic Auto Ltd | 328.15 | 133.39 |
| Arrow Greentech Ltd | 520.15 | 91.73 |
| Sunshield Chemicals Ltd | 873.85 | 61.54 |
| Kilitch Drugs (India) Ltd | 341.3 | 55.42 |
| Indo Borax and Chemicals Ltd | 176.85 | 39.69 |
| Amrutanjan Health Care Ltd | 744.95 | 24.41 |
| Borosil Ltd | 365.3 | 8.58 |
Best Stocks Held By Dipak Kanayalal Shah
The table below shows the Best Stocks Held By Dipak Kanayalal Shah based on the highest day Volume.
| Name | Close Price (rs) | Daily Volume (Shares) |
| Indo Borax and Chemicals Ltd | 176.85 | 77760 |
| Borosil Ltd | 365.3 | 62381 |
| Gujarat Themis Biosyn Ltd | 404.05 | 46992 |
| Arrow Greentech Ltd | 520.15 | 43980 |
| Amrutanjan Health Care Ltd | 744.95 | 37774 |
| Sunshield Chemicals Ltd | 873.85 | 14537 |
| Majestic Auto Ltd | 328.15 | 5102 |
| Kilitch Drugs (India) Ltd | 341.3 | 1550 |
Dipak Kanayalal Shah Net Worth
Dipak Kanayalal Shah, a prominent Indian investor, publicly holds 39 stocks with a net worth exceeding ₹177.9 crore, as per the latest corporate shareholdings filings. His diversified portfolio reflects a strategic approach to investment, highlighting his expertise in identifying high-potential opportunities across various sectors.
Shah’s investment strategy focuses on selecting stocks with robust fundamentals and significant growth potential. His diversified portfolio spans multiple industries, showcasing his ability to mitigate risks while maximizing returns. This approach underscores his adeptness in navigating market fluctuations and achieving consistent growth.
Beyond his investment activities, Shah’s keen market insight and thorough research contribute to his substantial net worth. His success serves as an inspiration to aspiring investors, emphasizing the importance of strategic planning and diversification in building a resilient and profitable portfolio.
Performance Metrics Of Dipak Kanayalal Shah’s Portfolio
The performance metrics of Dipak Kanayalal Shah’s portfolio demonstrate his strategic investment acumen, with a net worth exceeding ₹177.9 crore across 39 stocks. His diversified approach ensures robust returns and risk management, reflecting his expertise in stock selection and market analysis.
Shah’s portfolio is characterized by strong annual returns, driven by his focus on companies with solid fundamentals and significant growth prospects. His investments span diverse industries, ensuring a well-balanced risk profile and capitalizing on various market opportunities to maximize gains.
Additionally, Shah’s meticulous stock selection process emphasizes long-term value creation. By investing in companies with sustainable business models, he ensures steady appreciation and resilience against market volatility, underscoring his expertise and success in the financial market.
How do you invest in Dipak Kanayalal Shah’s portfolio stocks?
To invest in Dipak Kanayalal Shah’s portfolio stocks, start by identifying the 39 publicly disclosed stocks he holds. Open a brokerage account, research these stocks’ performance and fundamentals, and align your investments with your financial goals and risk tolerance.
Begin by thoroughly researching Shah’s portfolio stocks through financial news sources, corporate filings, and stock analysis platforms. Understand the market dynamics, industry trends, and growth potential of each stock to make informed investment decisions that reflect his strategic choices.
Diversify your investments to manage risk effectively. Regularly monitor your portfolio, stay updated on market trends and company developments, and adjust your holdings as needed to ensure alignment with your long-term financial objectives and optimize returns.
Benefits of Investing in Dipak Kanayalal Shah Stock Portfolio
The main benefit of investing in Dipak Kanayalal Shah’s stock portfolio is gaining access to a diversified selection of well-researched, high-potential stocks. His strategic investments aim to maximize long-term growth while minimizing risk, offering investors the opportunity to achieve consistent and substantial returns.
- Expertly Researched Stocks: Investing in Dipak Kanayalal Shah’s portfolio gives you access to stocks that have been thoroughly vetted by an experienced investor. His deep market knowledge and analytical skills ensure each stock is chosen for its strong fundamentals and significant growth potential, providing a solid foundation for your investments.
- Strategic Diversification: Shah’s portfolio spans various sectors, reducing overall risk through strategic diversification. This approach ensures that gains in one sector can offset losses in another, leading to more stable and resilient returns over time, even during market fluctuations.
- Long-Term Growth Focus: Shah emphasizes long-term value creation by investing in companies with sustainable business models and significant growth prospects. This focus on long-term performance can lead to substantial returns, making his portfolio ideal for investors seeking consistent and reliable growth.
- Proven Investment Acumen: With a net worth exceeding ₹177.9 crore, Shah’s successful investment track record speaks for itself. Following his portfolio choices can provide you with a blueprint for success, leveraging his proven strategies and market insights to enhance your own investment outcomes.
Challenges Of Investing in Dipak Kanayalal Shah’s Portfolio
The main challenge of investing in Dipak Kanayalal Shah’s portfolio is replicating his level of expertise and market insight. Identifying and analyzing high-potential stocks requires significant research and understanding. Additionally, market volatility and economic fluctuations can impact performance, necessitating constant monitoring and adjustments to maintain optimal returns.
- Replicating Expertise: Investing in Dipak Kanayalal Shah’s portfolio requires replicating his deep market insight and analytical skills. Identifying high-potential stocks demands thorough research and a comprehensive understanding of market dynamics, which can be challenging for novice investors without his level of experience.
- Market Volatility: Shah’s portfolio is not immune to market volatility. Economic changes, geopolitical events, and sector-specific fluctuations can impact stock performance. Investors must be prepared for sudden price swings and potential losses, requiring a robust risk management strategy to navigate these challenges effectively.
- Constant Monitoring: Maintaining an optimal investment portfolio similar to Shah’s demands constant monitoring and timely adjustments. Investors need to stay updated on market trends, company performance, and economic indicators to make informed decisions. This ongoing vigilance can be time-consuming and requires a proactive approach.
- Access to Information: Accessing the same level of detailed information as Shah can be difficult. Professional investors often have privileged access to market insights and company data that individual investors may find hard to obtain, potentially putting them at a disadvantage in making similarly informed investment decisions.
Introduction to Dipak Kanayalal Shah’s Portfolio
Borosil Ltd
The Market Cap of Borosil Ltd is ₹4,185.68 crore. The stock has recorded a monthly return of -2.62% and an annual return of 8.58%. It is currently 14.97% below its 52-week high.
Borosil Limited is primarily engaged in manufacturing and trading scientific, industrial, and consumer products. The company operates through two segments: Consumer Products (CP) and Scientific & Industrial Products (SIP). The CP segment focuses on microwavable and flameproof kitchenware, glass tumblers, hydra bottles, tableware, dinnerware, appliances, storage products, and steel-serve fresh items.
The SIP segment deals with laboratory glassware, instruments, liquid handling systems, and explosion-proof glassware. Borosil has two manufacturing facilities: one in Bharuch, Gujarat, and the other in Jaipur, Rajasthan. The Jaipur facility is dedicated exclusively to the CP division, while the Bharuch facility, primarily for SIP, also manufactures borosilicate glass products such as mugs, bottles, jars, glass tumblers, and other consumer glassware items.
Gujarat Themis Biosyn Ltd
The Market Cap of Gujarat Themis Biosyn Ltd is ₹2,935.16 crore. The stock has posted a monthly return of 5.20% and an annual return of 150.99%. It is currently 7.66% below its 52-week high.
Gujarat Themis Biosyn Limited, an India-based company, specializes in manufacturing pharmaceuticals and medicinal chemical products. The company focuses on producing and selling active pharmaceutical ingredients (API) through fermentation processes. It operates primarily in the bulk drugs segment, with a product portfolio that includes Rifamycin-O and Rifamycin-S.
Rifamycin-S, produced by the company, is an intermediate for the antibiotic Rifampicin, used to treat bacterial infections such as tuberculosis and leprosy. Rifamycin-O is an intermediate for Rifaximin, an antibiotic for traveler’s diarrhea and irritable bowel syndrome. The company’s R&D division is dedicated to developing fermentation cultures.
Amrutanjan Health Care Ltd
The Market Cap of Amrutanjan Health Care Ltd is ₹2,152.23 crore. The stock has recorded a monthly return of 15.15% and an annual return of 24.41%. It is currently 7.93% below its 52-week high.
Amrutanjan Health Care Limited is a company based in India that specializes in products for pain and congestion management, beverages, and hygiene. Its business segments include OTC Products, which focuses on manufacturing pain relievers, decongestants, and hygiene products, and Beverages, which produces fruit juices and oral hydration drinks.
The company offers a range of products under these segments. Pain management options include various balms and roll-ons designed to alleviate discomfort. For congestion relief, it provides products like nasal inhalers and cough syrups. Additionally, Amrutanjan produces a line of women’s hygiene products such as sanitary pads in various sizes, alongside their beverage offerings like Fruitnik and Fruitnik Electro+.
Arrow Greentech Ltd
The Market Cap of Arrow Greentech Ltd is ₹784.80 crore. The stock has posted a monthly return of 28.19% and an annual return of 91.73%. It is currently 15.16% below its 52-week high.
Arrow Greentech Limited is engaged in producing bio-degradable (green) and high-tech products. The company manufactures cast water-soluble films, bio-compostable products, and security films, operating through two segments: Green Products and Hightech Products. Its Green Products segment includes water-soluble films, bio-compostable products, and other eco-friendly items.
The Hightech Products segment of Arrow Greentech offers anti-counterfeit products, intellectual property rights (IPRs), and other advanced technologies. Their flagship product, the Watersol film, serves various industries such as agrochemicals, construction chemicals, dyes and pigments, embroidery, health and hygiene, and industrial engineering. The company’s BIOPLAST line includes products like BIOPLAST 105, BIOPLAST GF 106/02, and BIOPLAST GS 2189, providing alternatives to single-use toxic plastics.
Sunshield Chemicals Ltd
The Market Cap of Sunshield Chemicals Ltd is ₹642.55 crore. The stock has recorded a monthly return of 20.22% and an annual return of 61.54%. It is currently 19.93% below its 52-week high.
Sunshield Chemicals Limited, an India-based company, specializes in manufacturing and selling specialty chemicals for both domestic and international markets. The company offers a range of specially formulated and customized products used in sectors such as home and personal care, industrial formulations, paints and coatings, and agrochemicals.
Additionally, Sunshield Chemicals is involved in the surfactant and specialty functional chemicals business, serving customers in India, America, Europe, and the Far East. The company caters to diverse industries, including metal treatment, wire insulation, PVC stabilizers, inks, coatings, textiles, agrochemicals, polymers, plastics, rubber, and more. Their products include Tris 2-Hydroxyethyl Isocyanate, Hydroquinone Bis (2-Hydroxyethyl) Ether, antioxidants, and urea form.
Indo Borax and Chemicals Ltd
The Market Cap of Indo Borax and Chemicals Ltd is ₹567.51 crore. The stock has recorded a monthly return of -0.94% and an annual return of 39.69%. It is currently 34.58% below its 52-week high.
Indo Borax & Chemicals Limited is an India-based company involved in the manufacturing and selling of chemicals. Its product range includes borax, boric acid, and lithium hydroxide monohydrate. The company’s borax products include borax decahydrate crystal and borax decahydrate granular, while its boric acid offerings comprise Indian Pharmacopoeia (IP) grade, tech-grade granular, and tech-grade powder.
The company’s borax decahydrate crystal is used in fluxes and metallurgical operations, such as welding and brazing steel industry. Boric acid IP is utilized in products like eyewash, ointments, foot powder, shampoo, skin cream, mouthwash, and veterinary formulations. Borax decahydrate granular is employed in fused products like glass, ceramics, frits, and porcelain enamels, and also in fertilizers as micronutrients. Lithium hydroxide monohydrate is used in manufacturing lubricating greases.
Kilitch Drugs (India) Ltd
The Market Cap of Kilitch Drugs (India) Ltd is ₹548.89 crore. The stock has recorded a monthly return of -3.20% and an annual return of 55.42%. It is currently 37.71% below its 52-week high.
Kilitch Drugs (India) Limited is an India-based company engaged in the pharmaceutical business. It focuses on developing, manufacturing, and marketing finished dosages. The company’s product portfolio includes Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products.
Kilitch Drugs offers a wide range of products in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, and veterinary areas. Their oral formulations include tablets, capsules, dry syrups, and oral powders. The company’s medical devices feature the C-Seal brand, while its cosmetics range covers skincare, personal care, and hair care products. Manufacturing units are located in India and Ethiopia.
Majestic Auto Ltd
The Market Cap of Majestic Auto Ltd is ₹341.19 crore. The stock has posted a monthly return of 7.32% and an annual return of 133.39%. It is currently 27.70% below its 52-week high.
Majestic Auto Limited is an India-based company primarily involved in facility management and rental services. The company’s facility management encompasses space and infrastructure, including planning, design, workplace construction, lease, occupancy, maintenance, and furniture. Additionally, it covers people and organization services like catering, cleaning, ICT, HR, accounting, marketing, and hospitality.
The company provides commercial real estate office space on lease and manufactures electrical motor parts, such as die-cast rotors used in refrigerator compressors, washing machines, power steering, and electric fans. Majestic Auto’s subsidiaries include Majestic IT Services Limited and Emirates Technologies Private Limited, both of which are also engaged in facility management services.
Dipak Kanayalal Shah Portfolio – FAQs
Best Stocks Held By Dipak Kanayalal Shah #1: Borosil Ltd
Best Stocks Held By Dipak Kanayalal Shah #2: Gujarat Themis Biosyn Ltd
Best Stocks Held By Dipak Kanayalal Shah #3: Amrutanjan Health Care Ltd
Best Stocks Held By Dipak Kanayalal Shah #4: Arrow Greentech Ltd
Best Stocks Held By Dipak Kanayalal Shah #5: Sunshield Chemicals Ltd
The Top Best Stocks Held By Dipak Kanayalal Shah based on market capitalization.
The top stocks in Dipak Kanayalal Shah’s portfolio, based on market capitalization, include Borosil Ltd, Gujarat Themis Biosyn Ltd, Amrutanjan Health Care Ltd, Arrow Greentech Ltd, and Sunshield Chemicals Ltd. These companies span various sectors, reflecting his diversified investment strategy and expertise in identifying high-potential opportunities.
Dipak Kanayalal Shah’s net worth is over ₹177.9 crore, based on the latest corporate shareholdings filings. He publicly holds 39 stocks, showcasing his strategic investment approach and expertise. His diversified portfolio highlights his ability to identify high-potential opportunities and achieve substantial returns in the financial market.
Dipak Kanayalal Shah’s net worth is over ₹177.9 crore, based on the latest corporate shareholdings filings. He publicly holds 39 stocks, showcasing his strategic investment approach and expertise. His diversified portfolio highlights his ability to identify high-potential opportunities and achieve substantial returns in the financial market.
To invest in Dipak Kanayalal Shah’s portfolio stocks, identify the 39 publicly disclosed stocks he holds. Open a brokerage account, research these stocks’ performance and fundamentals, and align your investments with your financial goals and risk tolerance. Diversify your portfolio and regularly monitor market trends.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
